ustekinumab biosimilar (Reliance Life Sciences)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameustekinumab biosimilar (Reliance Life Sciences)
Drug Alias NameR-TPR-046
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin-12 receptor inhibitorsInterleukin-23 inhibitors
TargetsInterleukin-12 receptorInterleukin-23
Therapy Area/IndicationsPlaque psoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReliance Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReliance Life Sciences
Active IndicationsN/A
Inactive IndicationsPlaque psoriasis

Other Information

ATC CodeN/A
Related LinksN/A